Technology Jan 31, 2023 Arima Genomics to Offer NGS-Based Gene Fusion Test Through Protean BioDiagnostics CLIA Lab Jan 27, 2023 Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial Jan 26, 2023 Circulating Tumor DNA Testing Informs Best Second-Line Treatment for Gastrointestinal Stromal Tumors Premium Jan 26, 2023 NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients Jan 25, 2023 Labcorp, VieCure Collaborate on NGS, Software for Cancer Diagnosis Jan 25, 2023 Dana-Farber Tracks Impact of Precision Oncology Decision Support Program for GI Cancer Patients Premium Jan 25, 2023 Indivumed Sells Biospecimens Service Unit to CRO Crown Bioscience Jan 24, 2023 ImmPact Bio to Begin Phase I/II Trial of Bispecific CAR T-Cell Therapy in Aggressive Lymphoma Jan 23, 2023 Viewpoint Molecular Targeting Treats First Neuroendocrine Cancer Patients With Radiopharmaceutical Jan 20, 2023 Astellas' Zolbetuximab Plus Chemo Benefits CLDN18.2-Positive, HER2-Negative Gastric Cancer Patients Premium Jan 19, 2023 Liquid Biopsy Biomarker Score Predicts Relapse in Lymphoma Patients After CAR T-Cell Treatment Premium Jan 19, 2023 Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer Jan 19, 2023 Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug Jan 18, 2023 Penn Scientists Testing Out CAR T-Cell Therapy Gel to Prevent Breast Cancer Recurrence Post-Surgery Premium Jan 17, 2023 Yantai LNC Biotechnology to Use Sofie Biosciences Imaging Agent to ID Patients for Theranostic Trial Jan 17, 2023 PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test Jan 11, 2023 Bio4t2 Begins Dosing Solid Tumor Patients in First-In-Human CAR T-Cell Therapy Trial Jan 10, 2023 Could PD-L1/2 Structural Variants be the Next Pan-Cancer Predictive Immunotherapy Biomarker? Premium Jan 10, 2023 Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test Jan 9, 2023 Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform Load More Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
